Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling
- Aleksey V. Matveyenko1,
- David Liuwantara1,
- Tatyana Gurlo1,
- David Kirakossian1,
- Chiara Dalla Man2,
- Claudio Cobelli2,
- Morris F. White3,
- Kyle D. Copps3,
- Elena Volpi4,
- Satoshi Fujita4 and
- Peter C. Butler1⇓
- 1Larry Hillblom Islet Research Center, Division of Endocrinology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
- 2Department of Information Engineering, University of Padova, Padova, Italy
- 3Howard Hughes Medical Institute, Division of Endocrinology, Children’s Hospital, Boston, Massachusetts
- 4Department of Internal Medicine and Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas
- Corresponding author: Peter C. Butler, .
Insulin is secreted as discrete insulin secretory bursts at ∼5-min intervals into the hepatic portal vein, these pulses being attenuated early in the development of type 1 and type 2 diabetes mellitus (T2DM). Intraportal insulin infusions (pulsatile, constant, or reproducing that in T2DM) indicated that the pattern of pulsatile insulin secretion delivered via the portal vein is important for hepatic insulin action and, therefore, presumably for hepatic insulin signaling. To test this, we examined hepatic insulin signaling in rat livers exposed to the same three patterns of portal vein insulin delivery by use of sequential liver biopsies in anesthetized rats. Intraportal delivery of insulin in a constant versus pulsatile pattern led to delayed and impaired activation of hepatic insulin receptor substrate (IRS)-1 and IRS-2 signaling, impaired activation of downstream insulin signaling effector molecules AKT and Foxo1, and decreased expression of glucokinase (Gck). We further established that hepatic Gck expression is decreased in the HIP rat model of T2DM, a defect that correlated with a progressive defect of pulsatile insulin secretion. We conclude that the physiological pulsatile pattern of insulin delivery is important in hepatic insulin signaling and glycemic control. Hepatic insulin resistance in diabetes is likely in part due to impaired pulsatile insulin secretion.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-1462/-/DC1.
See accompanying commentary, p. 2228.
- Received October 14, 2011.
- Accepted April 4, 2012.
- © 2012 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.